Novel therapeutic nutrition

Dr Gene Bowman from the Nestlé Institute of Health Science argues that a multi-target approach using combinations of micronutrients and drugs could have beneficial effects on cognitive function in neurodegenerative brain disorders leading to synaptic degeneration (such as Alzheimer’s disease).

About speaker:
Dr Gene Bowman is a pioneer in nutrition and Alzheimer’s disease and has an international reputation as an authority in biomarkers of diet and individualised nutritional therapies for cognitive health. In 2014, he was recruited out of academia by Nestlé to build a brain nutrition research programme that generates knowledge for the renovation and innovation of nutritional products well suited for addressing the public health burden of age-related cognitive decline and dementias. He balances this initiative by also serving as Co-Chair and Co-Founder of the “Nutrition, Metabolism and Dementia” scientific professional interest area at the Alzheimer’s Association, Associate Professor of Neurology at OHSU, Associate Editor for the Journal of Alzheimer’s disease, and a current research portfolio that leverages over 40 million USD globally.